Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: Deng, Miao, Wang, Jianguang, Chen, Yanbin, Zhang, Like, Xie, Gangqiang, Liu, Qipeng, Zhang, Ting, Yuan, Pengfei, Liu, Dechun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940103/
https://ncbi.nlm.nih.gov/pubmed/27314680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.5401
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak